Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
99.39M | 162.51M | 171.88M | 187.88M | 188.13M | Gross Profit |
48.19M | 86.98M | 95.31M | 108.32M | 116.26M | EBIT |
-12.02M | -9.41M | -15.38M | 8.63M | -16.90M | EBITDA |
-691.00K | 16.74M | 11.50M | 35.58M | 5.95M | Net Income Common Stockholders |
-16.20M | -12.39M | -19.81M | 2.52M | -22.97M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
21.23M | 31.39M | 61.47M | 72.37M | 82.55M | Total Assets |
54.54M | 72.74M | 115.06M | 129.84M | 152.27M | Total Debt |
156.16M | 166.18M | 190.41M | 67.32M | 78.90M | Net Debt |
134.93M | 134.79M | 128.94M | -5.05M | -3.65M | Total Liabilities |
187.76M | 191.53M | 221.52M | 214.43M | 240.44M | Stockholders Equity |
-133.22M | -116.78M | -105.20M | -84.59M | -87.84M |
Cash Flow | Free Cash Flow | |||
8.35M | 11.63M | 6.01M | 25.34M | 7.11M | Operating Cash Flow |
11.81M | 13.28M | 10.47M | 30.32M | 11.35M | Investing Cash Flow |
-11.68M | 8.76M | -14.18M | -4.13M | -4.24M | Financing Cash Flow |
-11.16M | -40.73M | -17.63M | -36.83M | -46.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $58.43B | 13.10 | 27.44% | 5.31% | -3.11% | 15.29% | |
78 Outperform | HK$2.44B | 5.10 | 49.10% | 7.83% | 3.11% | -2.34% | |
60 Neutral | $6.56B | 11.42 | 3.23% | 4.27% | 2.37% | -21.19% | |
56 Neutral | HK$202.13M | 8.44 | 3.69% | 23.08% | -0.04% | -58.49% | |
45 Neutral | HK$230.35M | ― | ― | -56.57% | -49.64% |